Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$67.00 USD
-2.06 (-2.98%)
Updated May 17, 2024 04:00 PM ET
After-Market: $67.29 +0.29 (0.43%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/24/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 3.70% |
ABR | 1.00 |
Earnings ESP
|
0.33% |
---|---|
Current Year | -1.08 |
Next Year | -1.36 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.27 | -1.08 | -1.36 |
# of Estimates | 8 | 8 | 8 | 8 |
Most Recent Consensus | -0.28 | -0.29 | -1.14 | -1.64 |
High Estimate | -0.17 | -0.20 | -0.85 | -0.96 |
Low Estimate | -0.31 | -0.32 | -1.27 | -2.06 |
Year ago EPS | -0.19 | -0.23 | -0.91 | -1.08 |
Year over Year Growth Est. | -31.58% | -17.39% | -18.68% | -25.69% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 4 | 5 |
Down Last 60 Days | 3 | 3 | 4 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.27 | -1.08 | -1.36 |
7 Days Ago | -0.25 | -0.27 | -1.08 | -1.36 |
30 Days Ago | -0.27 | -0.28 | -1.10 | -1.37 |
60 Days Ago | -0.27 | -0.28 | -1.10 | -1.36 |
90 Days Ago | -0.28 | -0.29 | -1.12 | -1.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.27 | -1.09 | -1.42 |
Zacks Consensus Estimate | -0.25 | -0.27 | -1.08 | -1.36 |
Earnings ESP | 0.33% | 1.23% | -0.27% | -4.10% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.25 | -0.23 | -0.19 | NA |
Estimate | -0.27 | -0.25 | -0.22 | -0.21 | NA |
Difference | 0.01 | 0.00 | -0.01 | 0.02 | 0.01 |
Surprise | 3.70% | 0.00% | -4.55% | 9.52% | 2.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more